Open AccessMedicine
P. Triana, M. Dore, V. Cerezo, M. Cervantes, A. Sanchez, Miriam Miguel Ferrero, Mercedes Díaz González, J. López-Gutiérrez
2016.10.10EUROPEAN JOURNAL OF PEDIATRIC SURGERY
tlooto Summary
Sirolimus has become a new therapeutic option for patients with vascular anomalies that do not respond to other treatments, and important questions as what is the most appropriate dosage and for how long should the patient be treated remain unanswered.
Abstract
Abstract is not available.
Citation format
TRIANA, P., et al. Sirolimus in the treatment of vascular anomalies. EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2016, 27: 086–090.